RE:RE:RE:CCvalentinemasson wrote: The "company....there is revenue incoming that was produced in Q3 but could not be realized due to it being invoiced" statement leaves too much to speculation. After 6 weeks of Q3 and claimed revenue of $1 million, the last 6 weeks show slightly North of another $400,000. If this number after invoicing comes to at least $1 million revenue for the last 6 weeks of Q3, that is what everyone at least expects. Leading up to Q3 a run up was expected, instead the reverse happened. Let's hope the numbers jive as they should and the broader markets gain confidence in SZ's ability to play with the big boys in the pharmaceutical industry. Good luck all. VM.
True enough...that portion of revenue yet to be realized is in the air...no doubt....but to assume we made 1.5 mill in q3 is not accurate which a good chunk of poeple on this board reference too....according to law ...sure...but we did make more then that....come for covid..stay for cancer.....you can bet that we will prioritize healthcare providers and the first repsponders/nursing homes ect.... that work within their umbrella....this is our priority( for future Aristole acceptance) ....and this is not cash pay buisness...its invoiced ..45days.....
this will be a substancial amount of money thats missing in Q 3....mabye im wrong..but i doubt it